Treating and preventing microbial infections

a technology for microbial infections and treatment, applied in the direction of antibacterial agents, peptide/protein ingredients, antibacterial agents, etc., to achieve the effect of rapid treatment, reducing infection, and reducing infection

Active Publication Date: 2018-09-27
SNIPR BIOME APS
View PDF1 Cites 48 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0065]For example, the infection is an acute infection. For example, the infection is an acute infection that is rapidly treated. For example, the infection is treated rapidly—for example, the method comprises reducing the infection at least 100-fold by the first 30 minutes (eg, by the first 15 minutes) of the treatment. For example, the treatment is durable—for example, the reduction in infection persists for at least 30 minutes immediately after the first 30 minutes of the treatment. Also, optionally a reduction of the infection by at least 100-fold or 1000-fold is maintained for at least 60 minutes (eg, at least 120 minutes) after commencement of the treatment. Exemplification is provided below which surprisingly demonstrates these, such as a rapid killing that was durable around 3 hours after treatment commenced. For example, the method improves survival of the subject, or improves survival rates in humans or human patients suffering from infection by the microbes of the first species or strain.

Problems solved by technology

This is dangerous because the bacteria and their toxins can be carried through the bloodstream to a subject's entire body.
Septicaemia can quickly become life-threatening.
This inflammation can cause blood clots and block oxygen from reaching vital organs, resulting in organ failure.
Septic shock is fatal in many cases.
Bacteria from these infections enter the bloodstream and multiply rapidly, causing acute infection and immediate symptoms.
People who are already in the hospital for something else, such as a surgery, are at a higher risk of developing septicaemia.
These infections are often more dangerous because the bacteria may already be resistant to antibiotics.
There is a higher risk of developing septicaemia if the subject:has severe wounds or burnsis very young or very oldhas a compromised immune system, which can occur from diseases such as HIV or leukaemiahas a urinary or intravenous catheteris on mechanical ventilationis receiving medical treatments that weakens the immune system, such as chemotherapy or steroid injections
Even in the first stages of the illness, a person can look very sick.
These complications may be fatal if left untreated or if treatment is delayed for too long.
One complication of septicaemia is a serious drop in blood pressure.
Toxins released by the bacteria in the bloodstream can cause extremely low blood flow, which may result in organ or tissue damage.
This is a life-threatening condition that prevents enough oxygen from reaching your lungs and blood.
It often results in some level of permanent lung damage.
It can also damage the brain, which can lead to memory problems.
This leads to widespread inflammation throughout the body.
People with chronic diseases, such as HIV or cancer, are at a higher risk of sepsis.
This is because they have a weakened immune system and cannot fight off the infection on their own.
Sepsis causes millions of deaths globally each year and is the most common cause of death in people who have been hospitalized.
However, combination of antibiotics is not recommended for the treatment of sepsis without shock and in immunocompromised persons unless the combination is used to broaden the anti-bacterial activity.
Neonatal sepsis can be difficult to diagnose as newborns may be asymptomatic.
Acute bacterial infections can, in certain circumstances, be health-threatening or even life-threatening.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treating and preventing microbial infections
  • Treating and preventing microbial infections
  • Treating and preventing microbial infections

Examples

Experimental program
Comparison scheme
Effect test

embodiments

[0844]1. A method for treating a pathogenic bacterial infection in a human or animal subject caused by bacteria (first bacteria) of a first species or strain, the method comprising selectively killing first bacteria comprised by the subject by cutting a target site comprised by the genomes of the first bacteria, wherein the cutting is carried out using a programmable nuclease that is programmed to cut the target site, wherein the subject is suffering from a further disease or condition other than the pathogenic bacterial infection and the method comprises administering a therapy to the subject for treating or preventing the further disease or condition, wherein the nuclease treats the infection and the therapy is efficacious in the presence of the programmed nuclease to treat or prevent the disease or condition.[0845]2. The method of Embodiment 1, wherein the subject is a cancer patient and the therapy comprises administration of a haematopoietic stem cell transplant, chemotherapeut...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid and durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is particularly useful, for example, for treatment of microbes such as for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system. The invention also useful for the treatment of pathogenic bacterial infections in subjects receiving a treatment for a disease or condition, such as a transplant or a treatment for cancer, a viral infection or an autoimmune disease.

Description

SUBMISSION OF SEQUENCE LISTING ON ASCII TEXT FILE[0001]The content of the following submission on ASCII text file is incorporated herein by reference in its entirety: a computer readable form (CRF) of the Sequence Listing (file name: 786212000300SEQLIST.txt, date recorded: Apr. 30, 2018, size: 21 KB).TECHNICAL FIELD[0002]The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid or durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is also particularly useful, for example, for treatment of microbes for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.[0003]The invention also useful for the treatment of path...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/11A61P31/04A61K38/46A61K39/395
CPCC12N15/11A61P31/04A61K38/465A61K39/3955A61K39/39558C12N2310/20C07K16/2818C07K16/2827C12N15/111Y02A50/30C12N2320/31C12N2320/30
Inventor SOMMER, MORTENMARTINEZ, VIRGINIAVAN DER HELM, ERICHAABER, JAKOB KRAUSEDE SANTIAGO TORIO, ANAGRØNDAHL, CHRISTIANCLUBE, JASPER
Owner SNIPR BIOME APS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products